Basic Information
| LncRNA/CircRNA Name | MIR4435-2HG |
| Synonyms | NA |
| Region | GRCh38_2:111036776-111523376 |
| Ensemble | ENSG00000172965 |
| Refseq | NR_015395 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | qRT-PCR |
| Sample | colorectal cancer tissues,cell lines |
| Expression Pattern | up-regulated |
| Function Description | LncRNA MIR4435-2HG functions as an oncogene that promotes colorectal cancer progression, and likely represents a biomarker or therapeutic target of colorectal cancer. |
| Pubmed ID | 32141545 |
| Year | 2020 |
| Title | LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis |
External Links
| Links for MIR4435-2HG | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |